China Next Generation Cancer Diagnostics Market Size & Outlook
China next generation cancer diagnostics market, 2018-2030 (US$M)
Related Markets
China next generation cancer diagnostics market highlights
- The China next generation cancer diagnostics market generated a revenue of USD 904.6 million in 2023 and is expected to reach USD 2,064.2 million by 2030.
- The China market is expected to grow at a CAGR of 12.5% from 2024 to 2030.
- In terms of segment, next generation sequencing was the largest revenue generating technology in 2023.
- Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.
Next generation cancer diagnostics market data book summary
| Market revenue in 2023 | USD 904.6 million |
| Market revenue in 2030 | USD 2,064.2 million |
| Growth rate | 12.5% (CAGR from 2023 to 2030) |
| Largest segment | Next generation sequencing |
| Fastest growing segment | Next Generation Sequencing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Next Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays |
| Key market players worldwide | Johnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock |
Other key industry trends
- In terms of revenue, China accounted for 5.8% of the global next generation cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan next generation cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,064.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Next Generation Cancer Diagnostics Market Scope
Next Generation Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China next generation cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.
Next generation sequencing was the largest segment with a revenue share of 36.87% in 2023. Horizon Databook has segmented the China next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Health Organization report, China is critically affected by cancer. In 2012, China accounted for 3.07 million newly diagnosed cases. Market expansion strategies practiced by the operating entities of the industry to enhance the market presence is expected to enhance revenue generation from this region.
For instance, Clearbridge BioMedics partnered with LIDE Biotech for the introduction of CTC isolation facility in China. Such collaborations and agreements are intended to focus on the acceleration of therapeutic and drug discovery research in China thus propelling growth in the regional market.
Additionally, expansion strategy practiced by Illumina through joining forces with China's Amoy Diagnostics in order to create next-generation sequencing cancer tests for the Chinese clinical market and expanding its footprint in the country is anticipated to spur progress in Chinese next generation cancer diagnostics market.
Reasons to subscribe to China next generation cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China next generation cancer diagnostics market databook
-
Our clientele includes a mix of next generation cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China next generation cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into China next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China next generation cancer diagnostics market size, by technology, 2018-2030 (US$M)
China Next Generation Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
